Literature DB >> 16963754

T-cell responses to peptide fragments of the BK virus T antigen: implications for cross-reactivity of immune response to JC virus.

Jongming Li1, Jos Melenhorst, Nancy Hensel, Katyoun Rezvani, Giuseppe Sconocchia, Yasemin Kilical, Jean Hou, Blanche Curfman, Eugene Major, A John Barrett.   

Abstract

Infection with BK virus (BKV) induces both humoral and cellular immunity, but the viral antigens of T-antigen (T-ag) stimulating T-cell responses are largely unknown. To identify BKV-specific T cells in healthy individuals, peripheral blood lymphocytes were cultured with autologous dendritic cells (DCs) loaded with BKV lysate and T cells were screened for intracellular gamma interferon production after stimulation with an overlapping 15mer peptide library of the BKV T-ag. Among many immunogenic peptides identified, four T-ag peptides were identified as candidate major histocompatibility complex class I and II T-cell epitopes, restricted to human leukocyte antigen (HLA)-B*0702, -B*08, -DRB1*0301 and -DRB1*0901. Further, a candidate 9mer peptide, LPLMRKAYL, was confirmed to be restricted to HLA-B*0702 and -B*08. Because the polyomaviruses BKV, JC virus (JCV) and Simian virus 40 (SV40) share extensive sequence similarity in the immunogenic proteins T-ag and VP1, it was hypothesized that, in humans, these proteins contain conserved cytotoxic T-lymphocyte (CTL) target epitopes. Four HLA-restricted conserved epitopes of BKV, JCV and SV40 were identified: HLA-B*07, -B*08 and -DRB1*0901 for T-ag and -A*0201 for VP1. T cells cultured in vitro that were specific for one viral antigen recognized other conserved epitopes. CTLs generated from BKV T-ag and VP1 peptide were cytotoxic to DC targets pulsed with either BKV or JCV. Therefore, infection by one of the two viruses (BKV and JCV) could establish cross-immunity against the other. Although cross-cytotoxicity experiments were not performed with SV40, cross-recognition data from conserved antigen epitopes of polyomaviruses suggest strongly that cross-immunity might also exist among the three viruses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16963754     DOI: 10.1099/vir.0.82094-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  23 in total

1.  JC virus persistence following progressive multifocal leukoencephalopathy in multiple sclerosis patients treated with natalizumab.

Authors:  Caroline F Ryschkewitsch; Peter N Jensen; Maria Chiara Monaco; Eugene O Major
Journal:  Ann Neurol       Date:  2010-09       Impact factor: 10.422

2.  The polyomavirus BK large T-antigen-derived peptide elicits an HLA-DR promiscuous and polyfunctional CD4+ T-cell response.

Authors:  Bala Ramaswami; Iulia Popescu; Camila Macedo; Chunqing Luo; Ron Shapiro; Diana Metes; Geetha Chalasani; Parmjeet S Randhawa
Journal:  Clin Vaccine Immunol       Date:  2011-03-02

3.  BK virus capsid antibodies are associated with protection against subsequent development of PML in HIV-infected patients.

Authors:  Francesca Rossi; Xiuhong Li; Lisa Jacobson; Andrew J Levine; Yue Chen; Frank J Palella; Joseph Margolick; Raphael Viscidi
Journal:  Virology       Date:  2015-09-07       Impact factor: 3.616

Review 4.  BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies.

Authors:  George R Ambalathingal; Ross S Francis; Mark J Smyth; Corey Smith; Rajiv Khanna
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

Review 5.  BK polyomavirus diversity-Why viral variation matters.

Authors:  Jason T Blackard; Stella M Davies; Benjamin L Laskin
Journal:  Rev Med Virol       Date:  2020-03-03       Impact factor: 6.989

6.  HLA-A01-, -A03-, and -A024-binding nanomeric epitopes in polyomavirus BK large T antigen.

Authors:  Bala Ramaswami; Iulia Popescu; Camila Macedo; Diana Metes; Marta Bueno; Adriana Zeevi; Ron Shapiro; Raphael Viscidi; Parmjeet S Randhawa
Journal:  Hum Immunol       Date:  2009-05-14       Impact factor: 2.850

7.  BKV and JCV large T antigen-specific CD8+ T cell response in HLA A*0201+ kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy.

Authors:  Yiping Chen; Jennifer Trofe; Jennifer Gordon; Patrick Autissier; E Steve Woodle; Igor J Koralnik
Journal:  J Clin Virol       Date:  2008-03-04       Impact factor: 3.168

8.  Phenotypic and functional characterization of circulating polyomavirus BK VP1-specific CD8+ T cells in healthy adults.

Authors:  Michiel C van Aalderen; Ester B M Remmerswaal; Kirstin M Heutinck; Anja ten Brinke; Hanspeter Pircher; René A W van Lier; Ineke J M ten Berge
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

9.  An SV40 VP1-derived epitope recognized by CD8+ T cells is naturally processed and presented by HLA-A*0201 and cross-reactive with human polyomavirus determinants.

Authors:  Hephzibah Rani S Tagaram; Alan M Watson; Francois A Lemonnier; Kevin Staveley-O'Carroll; Satvir S Tevethia; Todd D Schell
Journal:  Virology       Date:  2008-04-10       Impact factor: 3.616

Review 10.  BK virus nephritis after renal transplantation.

Authors:  Aaron Dall; Sundaram Hariharan
Journal:  Clin J Am Soc Nephrol       Date:  2008-03       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.